Auditory steady state responses in a schizophrenia rat model probed by excitatory/inhibitory receptor manipulation

International Journal of Psychophysiology

Volumn 86, Issue 2, 2012, Pages 136-142

  Vohs, Jenifer L ^a,b   Chambers, R Andrew ^a   O'Donnell, Brian F ^c   Krishnan, Giri P ^c   Morzorati, Sandra L ^a  

^a INDIANA UNIVERSITY   (United States)

^b Larue D Carter Memorial Hospital   (United States)

^c INDIANA UNIVERSITY   (United States)

Author keywords

ASSRs; GABA; NMDA; NVHL; Schizophrenia; Synchronization

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; KETAMINE; MUSCIMOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUDITORY CORTEX; AUDITORY RESPONSE; AUDITORY STEADY STATE RESPONSE; AUDITORY STIMULATION; AUDITORY SYSTEM PARAMETERS; BRAIN DAMAGE; CONTROLLED STUDY; CORTICAL SYNCHRONIZATION; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; EXPERIMENTAL MODEL; HISTOPATHOLOGY; MALE; MEAN TRIAL POWER; NEONATAL VENTRAL HIPPOCAMPAL LESION; NERVE CELL NETWORK; NEUROTRANSMISSION; NONHUMAN; OSCILLATION; PATHOPHYSIOLOGY; PHASE LOCKING FACTOR; RAT; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; SCHIZOPHRENIA; WAKEFULNESS;

ACOUSTIC STIMULATION; ANIMALS; ANIMALS, NEWBORN; AUDITORY CORTEX; DISEASE MODELS, ANIMAL; EVOKED POTENTIALS, AUDITORY; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; GABA AGONISTS; HIPPOCAMPUS; MALE; NEURAL INHIBITION; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; SCHIZOPHRENIA;

EID: 84869097616     PISSN: 01678760     EISSN: 18727697     Source Type: Journal    
DOI: 10.1016/j.ijpsycho.2012.04.002     Document Type: Article

References (51)

1. Aghajanian G.K. Modeling "psychosis" in vitro by inducing disordered neuronal network activity in cortical brain slices. Psychopharmacology 2009, 206:575-585.
2. Al-Amin H.A., Weinberger D.R., Lipska B.K. Exaggerated MK-801-induced hyperactivity in rats with the neonatal lesion of the ventral hippocampus. Behavioural Pharmacology 2000, 11(3-4):269-278.
3. Bartos M., Vida I., Jonas P. Synaptic mechanisms of synchronized gamma oscillations in inhibitory interneuron networks. Nature Reviews. Neuroscience 2007, 8:45-56.
4. Benes F.M., Berretta S. GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 2001, 25:1-27.
5. Brenner C.A., Sporns O., Lysaker P.H., O'Donnell B.F. EEG synchronization to modulated auditory tones in schizophrenia, schizoaffective disorder, and schizotypal personality disorder. The American Journal of Psychiatry 2003, 160:2238-2240.
6. Brenner C.A., Krishnan G.P., Vohs J.L., Ahn W.Y., Hetrick W.P., Morzorati S.L., et al. Steady state responses: Electrophysiological assessment of sensory function in schizophrenia. Schizophrenia Bulletin 2009, 35:1065-1077.
7. Carlsson M., Svensson A. Interfering with glutamatergic neurotransmission by means of NMDA antagonist administration discloses the locomotor stimulatory potential of other transmitter systems. Pharmacology, Biochemistry, and Behavior 1990, 36:45-50.
8. Carlsson A., Waters N., Holm-Waters S., Tedroff J., Nilsson M., Carlsson M.L. Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annual Review of Pharmacology and Toxicology 2001, 41:237-260.
9. Cenquizca L.A., Swanson L.W. Spatial organization of direct hippocampal field CA1 axonal projections to the rest of the cerebral cortex. Brain Research Reviews 2007, 56(1):1-26.
10. Chambers R.A., Sentir A.M., Conroy S.K., Truitt W.A., Shekhar A. Cortical-striatal integration of cocaine history and prefrontal dysfunction in animal modeling of dual diagnosis. Biological Psychiatry 2010, 67:788-792.
11. Coyle J.T. The GABA-glutamate connection in schizophrenia: which is the proximate cause?. Biochemical Pharmacology 2004, 68:1507-1514.
12. Endo K., Hori T., Abe S., Asada T. Alterations in GABA(A) receptor expression in neonatal ventral hippocampal lesioned rats: Comparison of prepubertal and postpubertal periods. Synapse 2007, 61:357-366.
13. Ford J.M., Mathalon D.H. Neural synchrony in schizophrenia. Schizophrenia Bulletin 2008, 34:904-906.
14. Ford J.M., Krystal J.H., Mathalon D.H. Neural synchrony in schizophrenia: from networks to new treatments. Schizophrenia Bulletin 2007, 33:848-852.
15. Francois J., Ferrandon A., Koning E., Angst M.J., Sandner G., Nehlig A. Selective reorganization of GABAergic transmission in neonatal ventral hippocampal-lesioned rats. The International Journal of Neuropsychopharmacology 2009, 12:1097-1110.
16. Gonzalez-Burgos G., Lewis D.A. GABA neurons and the mechanisms of network oscillations: Implications for understanding cotical dysfunction in schizophrenia. Schizophrenia Bulletin 2008, 34:944-961.
17. Goto Y., Grace A.A. Dopamine modulation of hippocampal prefrontal cortical interaction drives memory-guided behavior. Cerebral Cortex 2008, 18:1407-1414.
18. Grunze H.C., Rainnie D.G., Hasselmo M.E., Barkai E., Hearn E.F., McCarley R.W., Greene R.W. NMDA-dependent modulation of CA1 local circuit inhibition. Journal of Neuroscience 1996, 16(6):2034-2043.
19. Homayoun H., Moghaddam B. NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. Journal of Neuroscience 2007, 27:11496-11500.
20. A receptor agonist muscimol on water intake in water-deprived rats. Physiology & Behavior 2002, 77:445-450.
21. Insausti R., Herrero M.T., Witter M.P. Entorhinal cortex of the rat: Cytoarchitectonic subdivisions and the origin and distribution of cortical efferents. Hippocampus 1997, 7:146-183.
22. Javitt D.C. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions. International Review of Neurobiology 2007, 78:69-108.
23. Javitt D.C., Spencer K.M., Thaker G.K., Winterer G., Hajos M. Neurophysiological biomarkers for drug development in schizophrenia. Nature Reviews. Drug Discovery 2008, 7:68-83.
24. Jay T.M., Witter M.P. Distribution of hippocampal CA1 and subicular efferents in the prefrontal cortex of the rat studied by means of anterograde tranport of Phaseolus vulgaris-leucoagglutinin. The Journal of Comparative Neurology 1991, 313:574-586.
25. Krishnan G.P., Hetrick W.P., Brenner C.A., Shekhar A., Steffen A.N., O'Donnell B.F. Steady state and induced auditory gamma deficits in schizophrenia. NeuroImage 2009, 47:1711-1719.
26. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Archives of General Psychiatry 1994, 51:199-214.
27. Krystal J.H., D'Souza D.C., Mathalon D., Perry E., Belger A., Hoffman R. NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacology 2003, 169:215-233.
28. Kwon J.S., O'Donnell B.F., Wallenstein G.V., Greene R.W., Hirayasu Y., Nestor P.G., et al. Gamma frequency-range abnormalities to auditory stimulation in schizophrenia. Archives of General Psychiatry 1999, 56:1001-1005.
29. Lazarewicz M.T., Ehrlichman R.S., Maxwell C.R., Gandal M.J., Finkel L.H., Siegel S.J. Ketamine modulates theta and gamma oscillations. Journal of Cognitive Neuroscience 2010, 22:1452-1464.
30. Lewis D.A., Moghaddam B. Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations. Archives of Neurology 2006, 63:1372-1376.
31. Light G.A., Hsu J.L., Hsieh M.H., Meyer-Gomes K., Sprock J., Swerdlow N.R., et al. Gamma band oscillations reveal neural network cortical coherence dysfunction in schizophrenia patients. Biological Psychiatry 2006, 60:1231-1240.
32. Lins O.G., Picton T.W. Auditory steady-state responses to multiple simultaneous stimuli. Electroencephalography and Clinical Neurophysiology 1995, 96:420-432.
33. Lipska B.K. Using animal models to test a neurodevelopmental hypothesis of schizophrenia. Journal of Psychiatry & Neuroscience 2004, 29(4):282-286.
34. Luck S.J., Mathalon D.H., O'Donnell B.F., Hamalainen M.S., Spencer K.M., Javitt D.C., et al. A roadmap for the development and validation of event-related potential biomarkers in schizophrenia research. Biological Psychiatry 2011, 70(1):28-34.
35. Macedo C.E., Angst M.J., Guiberteau T., Brasse D., O'Brien T.J., Sandner G. Acoustic hypersensitivity in adult rats after neonatal ventral hippocampus lesions. Behavioural Brain Research 2010, 207:161-168.
36. Makeig S., Debener S., Onton J., Delorme A. Mining event-related brain dynamics. Trends in Cognitive Sciences 2004, 8:204-210.
37. Moghaddam B., Adams B., Verma A., Daly D. Activation of glutamatergic neurotransmission by ketamine: A novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. Journal of Neuroscience 1997, 17:2921-2927.
38. O'Donnell P., Lewis B.L., Weinberger D.R., Lipska B.K. Neonatal hippocampal damage alters electrophysiological properties of prefrontal cortical neurons in adult rats. Cerebral Cortex 2002, 12:975-982.
39. Regan D. Human Brain Electrophysiology: Evoked Potentials and Evoked Magnetic Fields in Science and Medicine 1989, Elsevier, Amsterdam.
40. Roopun A.K., Cunningham M.O., Racca C., Alter K., Traub R.D., Whittington M.A. Region-specific changes in gamma and beta2 rhythms in NMDA receptor dysfunction models of schizophrenia. Schizophrenia Bulletin 2008, 34:962-973.
41. Spencer K.M., Salisbury D.F., Shenton M.E., McCarley R.W. Gamma-band auditory steady-state responses are impaired in first episode psychosis. Biological Psychiatry 2008, 64:369-375.
42. Teale P., Collins D., Maharajh K., Rojas D.C., Kronberg E., Reite M. Cortical source estimates of gamma band amplitude and phase are different in schizophrenia. NeuroImage 2008, 42:1481-1489.
43. Tseng K.Y., Lewis B.L., Lipska B.K., O'Donnell P. Post-pubertal disruption of medial prefrontal cortical dopamine-glutamate interactions in a developmental animal model of schizophrenia. Biological Psychiatry 2007, 62:730-738.
44. Tseng K.Y., Lewis B.L., Hashimoto T., Sesack S.R., Kloc M., Lewis D.A., et al. A neonatal ventral hippocampal lesion causes functional deficits in adult prefrontal cortical interneurons. Journal of Neuroscience 2008, 28:12691-12699.
45. Tseng K.Y., Chambers R.A., Lipska B.K. The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia. Behavioural Brain Research 2009, 204:295-305.
46. Uhlhaas P.J., Singer W. Abnormal neural oscillations and synchrony in schizophrenia. Nature Reviews. Neuroscience 2010, 11:100-113.
47. Vierling-Claassen D., Siekmeier P., Stufflebeam S., Kopell N. Modeling GABA alterations in schizophrenia: A link between impaired inhibition and altered gamma and beta range auditory entrainment. Journal of Neurophysiology 2008, 99:2656-2671.
48. Vohs J.L., Chambers R.A., Krishnan G.P., O'Donnell B.F., Hetrick W.P., Kaiser S.T., et al. Auditory sensory gating in the neonatal ventral hippocampal lesion model of schizophrenia. Neuropsychobiology 2009, 60:12-22.
49. Vohs J.L., Chambers R.A., Krishnan G.P., O'Donnell B.F., Berg S., Morzorati S.L. GABAergic modulation of the 40Hz auditory steady-state response in a rat model of schizophrenia. The International Journal of Neuropsychopharmacology 2010, 13:487-497.
50. Whittington M.A. Can brain rhythms inform on underlying pathology in schizophrenia?. Biological Psychiatry 2008, 63:728-729.
51. Whittington M.A., Cunningham M.O., Lebeau F.E., Racca C., Traub R.D. Multiple origins of the cortical gamma rhythm. Developmental Neurobiology 2010, 71(1):92-106.